Trump-touted hydroxychloroquine shows no benefit in COVID-19 prevention: study – Dunya News

(Reuters) – A malaria drug taken by U.S. President Donald Trump to prevent COVID-19 did not show any benefit versus placebo in reducing coronavirus infection among healthcare workers, according to clinical trial results published on Wednesday.
The study largely confirms results from a clinical trial in June that showed hydroxychloroquine was ineffective in preventing infection among people exposed to the new coronavirus.
Trump began backing hydroxychloroquine early in the pandemic and told rep…

Click here to view the original article.